
Joy Yee Jia Wu MD PhD
Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine
Associate Professor of Medicine Vice Chair - Basic Science
Join to view full profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-725-8418
Dr. Wu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joy Wu is an endocrinologist in Stanford, CA and is affiliated with Stanford Health Care and VA Palo Alto Health Care System. She received her medical degree from Duke University School of Medicine and has been in practice 16 years. She specializes in osteoporosis & bone metabolism medicine and is experienced in osteoporosis and calcium and bone metabolism.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2003
Duke University School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2012 - 2028
MA State Medical License 2003 - 2013
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- Mechanisms limiting the long-term anabolic effects of teriparatide (PTH 1-34) on bone.Clarissa Schmal, Joy Y Wu, Abbas Jafari
JBMR Plus. 2026-07-01 - Association of insulin resistance and fracture risk in the Osteoporotic Fractures in Men (MrOS) cohort.Jeonghoon Ha, Li-Yung Lui, Kristine Ensrud, Qian Xiao, Andrew R Hoffman
Journal of the Endocrine Society. 2026-06-01 - Challenges in the management of bone metastases: focus on differentiated thyroid cancer and neuroendocrine tumors.Julie Chen, Joy Y Wu
Journal of the Endocrine Society. 2026-05-01
Press Mentions
5 Signs of OsteoporosisSeptember 16th, 2021
National Shortages Threaten COVID-19 Response While Scientists Try to Get Needed ResourcesMarch 19th, 2020
Shortage of RNA Extraction Kits Hampers Efforts to Ramp up COVID-19 Coronavirus TestingMarch 19th, 2020
Grant Support
- Role Of Gsalpha In Regulating Osteoblast DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2012
- "In Vivo Reconstitution Of The Hematopoietic Niche"Office Of The Director, National Institutes Of Health2011
- Sclerostin And Gsalpha Signaling In OsteoblastsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
- Role Of Gsalpha Signaling In OsteoblastsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









